Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report

• Published in: Journal of integrative medicine 2021-03, Vol.19 (2), p.185-190
• Main Authors: Zhi, Na, Mo, Qian, Yang, Shuo, Qin, Yuan-xing, Chen, Hao, Wu, Zeng-guang, Lan, Cai-hong, Zhang, Jun, Li, Yin-long
• Format: Article
• Language: English
• Subjects: Administration, Oral; Case Report; Corona virus disease 2019; COVID-19 - complications; COVID-19 - virology; Drugs, Chinese Herbal - therapeutic use; Exudates and Transudates; Exudation; Female; Humans; Inflammation; Inflammation - drug therapy; Inflammation - etiology; Lung - drug effects; Lung - pathology; Magnoliopsida; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Pulmonary fibrosis; Pulmonary Fibrosis - drug therapy; Pulmonary Fibrosis - etiology; SARS-CoV-2; Traditional Chinese medicine
• ISSN: 2095-4964; 2095-4964
• DOI: 10.1016/j.joim.2020.11.005

After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient’s condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.